Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Triple-Blind, Randomized, Efficacy and Tolerability Comparison Study of PDFE-2304 Topical Solution Versus Minoxidil 5% Topical Solution for the Treatment of Androgenic Alopecia (AGA).

NCT07011485 is registered in ClinicalTrials.gov with PDFE Pharma Innovations FZCO as lead sponsor.

NCT NCT07011485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07011485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Triple-Blind, Randomized, Efficacy and Tolerability Comparison Study of PDFE-2304 Topical Solution Versus Minoxidil 5% Topical Solution for the Treatment of Androgenic Alopecia (AGA).
Lead sponsor
PDFE Pharma Innovations FZCO
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 14, 2025
Completion date
September 17, 2025
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia, androgenetic, androgenetic alopecia (aga), baldness